Brain Stimulation for Stuttering
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how mild, noninvasive electrical brain stimulation can help people who stutter. Researchers hope that transcranial alternating current stimulation (tACS) will improve speech fluency by enhancing communication between brain areas involved in speaking. Participants will receive three sessions, which may include real or placebo (inactive) treatments. Those who currently stutter, speak English as their primary language, and haven't had stuttering treatment in the past year might be a good fit for this study. As an unphased trial, this study offers participants the opportunity to contribute to groundbreaking research that could lead to new treatments for stuttering.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this brain stimulation technique is safe for treating stuttering?
Research has shown that transcranial alternating current stimulation (tACS) is generally safe. In one study with 18 healthy volunteers, using tACS at a frequency of 5 kHz for 10 minutes at a strength of 1 mA did not raise any safety concerns, indicating that the treatment is usually well-tolerated at these settings.
tACS is a noninvasive method, meaning it doesn't involve surgery or cutting into the body. While no major negative effects have been reported, it might cause minor discomforts like a tingling sensation on the skin.
Overall, current studies support the safety of tACS, making it a promising option for exploring its effects on stuttering.12345Why are researchers excited about this trial?
Researchers are excited about transcranial alternating current stimulation (tACS) for stuttering because it offers a novel approach to treating this speech disorder. Unlike traditional therapies that often focus on speech techniques and behavioral interventions, tACS uses mild electrical currents to directly stimulate brain activity, potentially targeting the underlying neural pathways associated with stuttering. This method could offer a non-invasive and dynamic way to address stuttering at its source, providing new hope for individuals who have not found success with existing treatments.
What evidence suggests that transcranial alternating current stimulation (tACS) is effective for stuttering?
Research suggests that transcranial alternating current stimulation (tACS), which participants in this trial will receive, might help reduce stuttering. Similar methods, such as transcranial direct current stimulation (tDCS), have significantly lessened stuttering. tACS sends gentle electrical currents to the brain to improve communication between brain areas during speech. This non-invasive method does not involve surgery. While the potential is promising, further research is needed to confirm the effectiveness of tACS for stuttering.12367
Who Is on the Research Team?
Soo-Eun Chang, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for adults who stutter, including those whose stuttering began in childhood or adulthood. Participants must be able to undergo noninvasive brain stimulation and participate in speech tasks. Specific medical conditions or treatments that could interfere with the study are reasons for exclusion.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants undergo baseline assessments including standardized tests of speech, language, hearing, and working memory, as well as MRI and EEG
Treatment
Participants receive 5 sessions of tACS, which can be active or sham, paired with fluency-induced speech (choral reading)
Follow-up
Participants are monitored for changes in speech fluency and brain activity after treatment, with a follow-up phone call one month later
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Alternating Current Stimulation (tACS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor